TNGX Q3'26 Earnings: revenue estimate is 0 USD
Moins d'1 minute de lecture
TNGX (Tango Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.35) USD. Learn more details at TNGX Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 53.81 M | — | — | — | — |
| Revenue Estimate | 53.80 M | 500.40 K | 578.09 K | — | — |
| Revenue Surprise | +0.02% | -100.00% | -100.00% | ||
| EPS Reported | 0.14 | (0.29) | (0.32) | (0.37) | |
| EPS Estimate | (0.05) | (0.32) | (0.31) | (0.32) | (0.35) |
| EPS Surprise | +376.92% | +8.86% | -2.01% | -16.64% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.